A prospective randomized study of CHOP versus CHOP plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin's lymphoma: The International Oncology Study Group NHL1 study


Giles F., Shan J., Advani S., Akan H., Aydogdu I., Aziz Z., ...Daha Fazla

LEUKEMIA & LYMPHOMA, cilt.40, ss.95-103, 2000 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 40
  • Basım Tarihi: 2000
  • Doi Numarası: 10.3109/10428190009054885
  • Dergi Adı: LEUKEMIA & LYMPHOMA
  • Sayfa Sayıları: ss.95-103

Özet

The addition of a brief alpha interferon regimen to each CHOP induction cycle, plus one year of alpha interferon thrice weekly maintenance therapy, has no early effect on response rates or survival in patients with Intermediate or High grade cell NHL.